Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1255

    1.

    Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.

    Jemal A, Ward E, Thun MJ.

    Breast Cancer Res. 2007;9(3):R28.

    PMID:
    17477859
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.

    Hausauer AK, Keegan TH, Chang ET, Clarke CA.

    Breast Cancer Res. 2007;9(6):R90.

    PMID:
    18162138
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

    Glass AG, Lacey JV Jr, Carreon JD, Hoover RN.

    J Natl Cancer Inst. 2007 Aug 1;99(15):1152-61. Epub 2007 Jul 24.

    PMID:
    17652280
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Trends in breast cancer by race and ethnicity: update 2006.

    Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M.

    CA Cancer J Clin. 2006 May-Jun;56(3):168-83.

    PMID:
    16737949
    [PubMed - indexed for MEDLINE]
    5.

    Trends in incidence rates of invasive lobular and ductal breast carcinoma.

    Li CI, Anderson BO, Daling JR, Moe RE.

    JAMA. 2003 Mar 19;289(11):1421-4.

    PMID:
    12636465
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998.

    Li CI, Daling JR, Malone KE.

    J Clin Oncol. 2003 Jan 1;21(1):28-34.

    PMID:
    12506166
    [PubMed - indexed for MEDLINE]
    7.

    The greater impact of menopause on ER- than ER+ breast cancer incidence: a possible explanation (United States).

    Tarone RE, Chu KC.

    Cancer Causes Control. 2002 Feb;13(1):7-14.

    PMID:
    11899120
    [PubMed - indexed for MEDLINE]
    8.

    Trends in breast cancer by race and ethnicity.

    Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M.

    CA Cancer J Clin. 2003 Nov-Dec;53(6):342-55. Erratum in: CA Cancer J Clin. 2004 May-Jun;54(3):181.

    PMID:
    15224974
    [PubMed - indexed for MEDLINE]
    9.

    Risk factors for breast cancer according to estrogen and progesterone receptor status.

    Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE.

    J Natl Cancer Inst. 2004 Feb 4;96(3):218-28.

    PMID:
    14759989
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups.

    Chu KC, Anderson WF.

    Breast Cancer Res Treat. 2002 Jun;74(3):199-211.

    PMID:
    12206512
    [PubMed - indexed for MEDLINE]
    11.

    Recent trends in U.S. breast cancer incidence, survival, and mortality rates.

    Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, Edwards BK.

    J Natl Cancer Inst. 1996 Nov 6;88(21):1571-9.

    PMID:
    8901855
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.

    Mariotto AB, Feuer EJ, Harlan LC, Abrams J.

    J Natl Cancer Inst Monogr. 2006;(36):7-15.

    PMID:
    17032888
    [PubMed - indexed for MEDLINE]
    13.

    Recent trends in breast cancer among younger women in the United States.

    Brinton LA, Sherman ME, Carreon JD, Anderson WF.

    J Natl Cancer Inst. 2008 Nov 19;100(22):1643-8. Epub 2008 Nov 11.

    PMID:
    19001605
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.

    Dunnwald LK, Rossing MA, Li CI.

    Breast Cancer Res. 2007;9(1):R6.

    PMID:
    17239243
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis.

    Jatoi I, Chen BE, Anderson WF, Rosenberg PS.

    J Clin Oncol. 2007 May 1;25(13):1683-90. Epub 2007 Apr 2.

    PMID:
    17404367
    [PubMed - indexed for MEDLINE]
    16.

    Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement.

    Cronin-Fenton DP, Ries LA, Clegg LX, Edwards BK.

    J Natl Cancer Inst. 2007 Jul 4;99(13):1044-9. Epub 2007 Jun 27.

    PMID:
    17596573
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival.

    Hill TD, Khamis HJ, Tyczynski JE, Berkel HJ.

    Ann Epidemiol. 2005 Nov;15(10):773-80.

    PMID:
    16257362
    [PubMed - indexed for MEDLINE]
    18.

    The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.

    Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC.

    Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1763-9. Epub 2009 May 19.

    PMID:
    19454615
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland.

    Verkooijen HM, Fioretta G, Vlastos G, Morabia A, Schubert H, Sappino AP, Pelte MF, Schäfer P, Kurtz J, Bouchardy C.

    Int J Cancer. 2003 May 10;104(6):778-81.

    PMID:
    12640687
    [PubMed - indexed for MEDLINE]
    20.

    Impact of reporting delay and reporting error on cancer incidence rates and trends.

    Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF.

    J Natl Cancer Inst. 2002 Oct 16;94(20):1537-45.

    PMID:
    12381706
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk